Terry Kim, MD, joining Alcon as chief medical officer and head of global medical safety
March 26th 2024According to Alcon, as CMO, Terry Kim, MD, will continue to integrate scientific and clinical priorities across Alcon’s Surgical and Vision Care franchises, with a focus on meeting the needs of patients and eye care practitioners across the globe.
RadiusXR publishes NOVA clinical trial results for virtual reality perimetry
March 26th 2024The NOVA clinical trial has found statistical non-inferiority to current clinical standards for sensitivities at individual test locations, glaucoma staging using Medicare definitions, and an exceptionally high correlation of 0.94 in mean deviation.
Diagnosis and management of solar retinopathy
March 21st 2024Solar retinopathy is caused by prolonged or high intensity exposure of the fovea centralis to light energy. Suspected cases of solar retinopathy may require urgent referral to an ophthalmologist for diagnosis, and to eliminate treatable causes for central visual disturbance.
Connecticut city official files lawsuit against ophthalmologist he claims damaged his vision
March 20th 2024In court documents in Connecticut Superior Court in Bridgeport, Isidore Sobkowski claims surgeons at the Wilton Surgery Center failed to properly clean their instruments resulting in him contracting a sight-threatening eye infection.
Nicox publishes results of Phase 3 trial of NCX 470 for treatment of glaucoma
March 20th 2024According to the company, NCX 470 is a novel NO-donating bimatoprost eye drop, is currently in Phase 3 clinical development for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.